Estramustine and vinblastine (EV) regimen for advanced hormone-refractory prostate cancer

James Waddell, Dominic A. Solimando

Research output: Contribution to journalReview article

Abstract

The increasing complexity of cancer chemotherapy makes it mandatory that pharmacists be familiar with these highly toxic agents. This column reviews various issues related to the preparation, dispensing, and administration of cancer chemotherapy, both commercially available and investigational.

Original languageEnglish (US)
JournalHospital Pharmacy
Volume37
Issue number7
DOIs
StatePublished - Jan 1 2002

Fingerprint

Estramustine
Chemotherapy
Vinblastine
Refractory materials
Prostatic Neoplasms
Hormones
Drug Therapy
Poisons
Pharmacists
Neoplasms

All Science Journal Classification (ASJC) codes

  • Pharmacy
  • Pharmacology
  • Pharmacology (medical)

Cite this

Estramustine and vinblastine (EV) regimen for advanced hormone-refractory prostate cancer. / Waddell, James; Solimando, Dominic A.

In: Hospital Pharmacy, Vol. 37, No. 7, 01.01.2002.

Research output: Contribution to journalReview article

@article{add7e4a226fa45cdb382c17f4677b539,
title = "Estramustine and vinblastine (EV) regimen for advanced hormone-refractory prostate cancer",
abstract = "The increasing complexity of cancer chemotherapy makes it mandatory that pharmacists be familiar with these highly toxic agents. This column reviews various issues related to the preparation, dispensing, and administration of cancer chemotherapy, both commercially available and investigational.",
author = "James Waddell and Solimando, {Dominic A.}",
year = "2002",
month = "1",
day = "1",
doi = "10.1177/001857870203700702",
language = "English (US)",
volume = "37",
journal = "Hospital Pharmacy",
issn = "0018-5787",
publisher = "Facts and Comparisons",
number = "7",

}

TY - JOUR

T1 - Estramustine and vinblastine (EV) regimen for advanced hormone-refractory prostate cancer

AU - Waddell, James

AU - Solimando, Dominic A.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - The increasing complexity of cancer chemotherapy makes it mandatory that pharmacists be familiar with these highly toxic agents. This column reviews various issues related to the preparation, dispensing, and administration of cancer chemotherapy, both commercially available and investigational.

AB - The increasing complexity of cancer chemotherapy makes it mandatory that pharmacists be familiar with these highly toxic agents. This column reviews various issues related to the preparation, dispensing, and administration of cancer chemotherapy, both commercially available and investigational.

UR - http://www.scopus.com/inward/record.url?scp=0036067012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036067012&partnerID=8YFLogxK

U2 - 10.1177/001857870203700702

DO - 10.1177/001857870203700702

M3 - Review article

VL - 37

JO - Hospital Pharmacy

JF - Hospital Pharmacy

SN - 0018-5787

IS - 7

ER -